PATENT CLAIM ANALYSIS

Application Number: 15886659
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "468000"]

Abstract:
Opioid controlled release formulation resistant to alcohol extraction of the opioid.

Claim (Index 14):
Use according to any one of he preceding claims, wherein the opioid salt is a combination of an opioid agonist salt and an opioid antagonist salt, the combination providing an analgesic effect, wherein the opioid antagonist is selected form the group of naloxone, naltrexone and nalorphine in the form of pharmaceutically acceptable salts thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13900873', '13333560', '13901218', '14040535', '15245338']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7060649411182713
- 35 USC 102 Novelty (BERT): 0.5539138857992464
- Combined Prediction Score: 0.6908498355863689
- Mean Citation Score: 395.594268
- Max Citation Score: 406.89218
- Similarity Product: 323.28917325881963

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test